Rapid extraction-free detection of the R132H isocitrate dehydrogenase mutation in glioma using colorimetric peptide nucleic acid-loop mediated isothermal amplification (CPNA-LAMP).
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
09
12
2022
accepted:
03
09
2023
medline:
25
9
2023
pubmed:
21
9
2023
entrez:
21
9
2023
Statut:
epublish
Résumé
The R132H isocitrate dehydrogenase one (IDH1) mutation is a prognostic biomarker present in a subset of gliomas and is associated with heightened survival when paired with aggressive surgical resection. In this study, we establish proof-of-principle for rapid colorimetric detection of the IDH1-R132H mutation in tumor samples in under 1 hour without the need for a nucleic acid extraction. Colorimetric peptide nucleic acid loop-mediated isothermal amplification (CPNA-LAMP) utilizes 4 conventional LAMP primers, a blocking PNA probe complementary to the wild-type sequence, and a self-annealing loop primer complementary to the single nucleotide variant to only amplify the DNA sequence containing the mutation. This assay was evaluated using IDH1-WT or IDH1-R132H mutant synthetic DNA, wild-type or IDH1-R132H mutant U87MG cell lysates, and tumor lysates from archived patient samples in which the IDH1 status was previously determined using immunohistochemistry (IHC). Reactions were performed using a hot water bath and visually interpreted as positive by a pink-to-yellow color change. Results were subsequently verified using agarose gel electrophoresis. CPNA-LAMP successfully detected the R132H single nucleotide variant, and results from tumor lysates yielded 100% concordance with IHC results, including instances when the single nucleotide variant was limited to a portion of the tumor. Importantly, when testing the tumor lysates, there were no false positive or false negative results.
Identifiants
pubmed: 37733671
doi: 10.1371/journal.pone.0291666
pii: PONE-D-22-33854
pmc: PMC10513201
doi:
Substances chimiques
Peptide Nucleic Acids
0
Isocitrate Dehydrogenase
EC 1.1.1.41
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0291666Informations de copyright
Copyright: © 2023 Choate et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interets exist.
Références
Nucleic Acids Res. 2000 Jun 15;28(12):E63
pubmed: 10871386
Neurosurg Clin N Am. 2021 Jan;32(1):23-29
pubmed: 33223023
PLoS One. 2019 Dec 27;14(12):e0219724
pubmed: 31881020
PLoS One. 2016 Mar 21;11(3):e0151654
pubmed: 26999437
Oncol Lett. 2020 Feb;19(2):1322-1330
pubmed: 31966064
J Neurosurg. 2022 Mar 4;:1-8
pubmed: 35245899
Neuro Oncol. 2018 Apr 9;20(5):608-620
pubmed: 29036500
Neuro Oncol. 2014 Jan;16(1):81-91
pubmed: 24305719
Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10743-10748
pubmed: 28916733
JAMA Oncol. 2020 Apr 1;6(4):495-503
pubmed: 32027343
Curr Issues Mol Biol. 1999;1(1-2):89-104
pubmed: 11475704
Hum Mutat. 2010 Dec;31(12):1360-5
pubmed: 20886613
Science. 2008 Sep 26;321(5897):1807-12
pubmed: 18772396
Radiother Oncol. 2015 Sep;116(3):381-7
pubmed: 26328938
Haematologica. 2012 Sep;97(9):1394-400
pubmed: 22315499
Front Oncol. 2016 Jan 29;6:16
pubmed: 26858939
PLoS One. 2017 Feb 15;12(2):e0169011
pubmed: 28199317
Br J Biomed Sci. 2022 Jan 31;79:10208
pubmed: 35996504
Int J Biochem Cell Biol. 2016 Apr;73:72-81
pubmed: 26860959
J Microbiol. 2015 Jan;53(1):1-5
pubmed: 25557475
Cell Rep. 2017 Apr 11;19(2):389-400
pubmed: 28402860
Neuro Oncol. 2021 Aug 2;23(8):1231-1251
pubmed: 34185076
Science. 2009 Apr 10;324(5924):261-5
pubmed: 19359588